TrialBreast cancer research and treatment2024

The role of serum thymidine kinase 1 activity in neoadjuvant-treated HER2-positive breast cancer: biomarker analysis from the Swedish phase II randomized PREDIX HER2 trial.

Yajing Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.